GUTS
Price
$1.49
Change
-$0.14 (-8.59%)
Updated
May 6, 04:59 PM (EDT)
Capitalization
73.46M
13 days until earnings call
KYTX
Price
$2.01
Change
-$0.12 (-5.63%)
Updated
May 6, 04:59 PM (EDT)
Capitalization
86.87M
14 days until earnings call
Ad is loading...

GUTS vs KYTX

Header iconGUTS vs KYTX Comparison
Open Charts GUTS vs KYTXBanner chart's image
Fractyl Health
Price$1.49
Change-$0.14 (-8.59%)
Volume$744
Capitalization73.46M
Kyverna Therapeutics
Price$2.01
Change-$0.12 (-5.63%)
Volume$15.74K
Capitalization86.87M
GUTS vs KYTX Comparison Chart
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. KYTX commentary
May 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a StrongBuy and KYTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 07, 2025
Stock price -- (GUTS: $1.63 vs. KYTX: $2.13)
Brand notoriety: GUTS and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 159% vs. KYTX: 70%
Market capitalization -- GUTS: $73.46M vs. KYTX: $86.87M
GUTS [@Biotechnology] is valued at $73.46M. KYTX’s [@Biotechnology] market capitalization is $86.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GUTS and KYTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 5 TA indicator(s) are bullish while KYTX’s TA Score has 5 bullish TA indicator(s).

  • GUTS’s TA Score: 5 bullish, 5 bearish.
  • KYTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а +35.83% price change this week, while KYTX (@Biotechnology) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.32%. For the same industry, the average monthly price growth was +9.19%, and the average quarterly price growth was -13.77%.

Reported Earning Dates

GUTS is expected to report earnings on May 19, 2025.

KYTX is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($86.9M) has a higher market cap than GUTS($73.5M). GUTS YTD gains are higher at: -20.874 vs. KYTX (-43.048). GUTS has higher annual earnings (EBITDA): -92.85M vs. KYTX (-108.46M). KYTX has more cash in the bank: 322M vs. GUTS (67.5M). KYTX has less debt than GUTS: KYTX (9.14M) vs GUTS (62.5M). GUTS has higher revenues than KYTX: GUTS (93K) vs KYTX (0).
GUTSKYTXGUTS / KYTX
Capitalization73.5M86.9M85%
EBITDA-92.85M-108.46M86%
Gain YTD-20.874-43.04848%
P/E RatioN/AN/A-
Revenue93K0-
Total Cash67.5M322M21%
Total Debt62.5M9.14M684%
TECHNICAL ANALYSIS
Technical Analysis
GUTSKYTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 7 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGKX19.69N/A
N/A
BlackRock Advantage Small Cap Gr K
TRLWX22.29N/A
N/A
Nuveen Large Cap Value W
AIEMX11.03N/A
N/A
Alger Emerging Markets I
EMECX10.77N/A
N/A
Ashmore Emerging Markets Equity C
IYBIX23.40-0.04
-0.17%
Macquarie Balanced Fund Class I

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with IPSC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
+3.16%
IPSC - GUTS
34%
Loosely correlated
+2.02%
CABA - GUTS
34%
Loosely correlated
-4.48%
INZY - GUTS
34%
Loosely correlated
-8.02%
KYTX - GUTS
34%
Loosely correlated
-6.58%
PRME - GUTS
33%
Loosely correlated
-6.55%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-6.58%
CABA - KYTX
47%
Loosely correlated
-4.48%
IMNM - KYTX
45%
Loosely correlated
-3.95%
CRSP - KYTX
43%
Loosely correlated
-1.65%
PRME - KYTX
42%
Loosely correlated
-6.55%
TRDA - KYTX
40%
Loosely correlated
-1.52%
More